2023 Financial summary

Half Year results

Key figures

FINANCIAL REVIEW

For the six months ended 30 June

in millions of Swiss francs except earnings per share data

2023

2022

Sales

3,535

3,652

Gross profit

1,448

1,459

as % of sales

41.0%

40.0%

EBITDA a

763

816

as % of sales

21.6%

22.4%

Operating income

586

631

as % of sales

16.6%

17.3%

Income attributable to non-controlling interests

-

-

Income attributable to equity holders of the parent

449

440

as % of sales

12.7%

12.1%

Earnings per share - basic (CHF)

48.69

47.74

Earnings per share - diluted (CHF)

48.53

47.52

Operating cash flow

340

131

as % of sales

9.6%

3.6%

Free cash flow b

104

(147)

as % of sales

2.9%

(4.0%)

  1. EBITDA defined as Earnings Before Interest (and other financial income (expense), net), Tax, Depreciation and Amortisation, corresponds to operating income before depreciation, amortisation and impairment of long-lived assets.
  2. Free Cash Flow refers to operating cash flow after net investments, interest paid, lease payments and purchase and sale of own equity instruments.

Givaudan - 2023 Financial summary  2

Key figures

GROUP

For the six months ended 30 June

in millions of Swiss francs

2023

2022

Sales to third parties

3,535

3,652

EBITDA a

763

816

as % of sales

21.6%

22.4%

One off items

(40)

(4)

Comparable EBITDA

803

820

as % of sales

22.7%

22.5%

Operating income

586

631

as % of sales

16.6%

17.3%

  1. EBITDA defined as Earnings Before Interest (and other financial income (expense), net), Tax, Depreciation and Amortisation, corresponds to operating income before depreciation, amortisation and impairment of long-lived assets.

TASTE & WELLBEING

For the six months ended 30 June

in millions of Swiss francs

2023

2022

Sales to third parties

1,863

2,006

EBITDA a

380

454

as % of sales

20.4%

22.6%

One off items

(17)

(1)

Comparable EBITDA

397

455

as % of sales

21.3%

22.7%

Operating income

273

340

as % of sales

14.6%

16.9%

  1. EBITDA defined as Earnings Before Interest (and other financial income (expense), net), Tax, Depreciation and Amortisation, corresponds to operating income before depreciation, amortisation and impairment of long-lived assets.

FRAGRANCE & BEAUTY

For the six months ended 30 June

in millions of Swiss francs

2023

2022

Sales to third parties

1,672

1,646

EBITDA a

383

362

as % of sales

22.9%

22.0%

One off items

(23)

(3)

Comparable EBITDA

406

365

as % of sales

24.3%

22.2%

Operating income

313

291

as % of sales

18.7%

17.7%

  1. EBITDA defined as Earnings Before Interest (and other financial income (expense), net), Tax, Depreciation and Amortisation, corresponds to operating income before depreciation, amortisation and impairment of long-lived assets.

Givaudan - 2023 Financial summary  3

Consolidated financial statements

CONSOLIDATED INCOME STATEMENT

For the six months ended 30 June

in millions of Swiss francs, except for earnings per share data

2023

2022

Sales

3,535

3,652

Cost of sales

(2,087)

(2,193)

Gross profit

1,448

1,459

as % of sales

41.0%

40.0%

Selling, marketing and distribution expenses

(449)

(450)

Research and product development expenses

(262)

(268)

Administration expenses

(96)

(102)

Share of results of joint ventures and associates

3

11

Other operating income

16

16

Other operating expense

(74)

(35)

Operating income

586

631

as % of sales

16.6%

17.3%

Financing costs

(61)

(48)

Other financial income (expense), net

(9)

(71)

Income before taxes

516

512

Income taxes

(67)

(72)

Income for the period

449

440

Attribution

Income attributable to non-controlling interests

-

-

Income attributable to equity holders of the parent

449

440

as % of sales

12.7%

12.1%

Earnings per share − basic (CHF)

48.69

47.74

Earnings per share − diluted (CHF)

48.53

47.52

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the six months ended 30 June

in millions of Swiss francs

2023

2022

Income for the period

449

440

Items that may be reclassified to the income statement

Cash flow hedges

Movement in fair value, net

(25)

181

Gains (losses) removed from equity and recognised in the consolidated

income statement

4

5

Movement on income tax

2

(14)

Exchange differences arising on translation of foreign opera-

tions

Movement in fair value arising on hedging instruments of the net assets in

foreign operations

31

25

Change in currency translation

(148)

(58)

Movement on income tax

(2)

(3)

Items that will not be reclassified to the income statement

Defined benefit pension plans

Remeasurement gains (losses) of post employment benefit obligations

4

157

Movement on income tax

(1)

(25)

Other comprehensive income for the period

(135)

268

Total comprehensive income for the period

314

708

Attribution

Total comprehensive income attributable to non-controlling interests

-

-

Total comprehensive income attributable to equity holders of the parent

314

708

Givaudan - 2023 Financial summary  4

Consolidated financial statements

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

30 June

31 December

in millions of Swiss francs

2023

2022

Assets

Cash and cash equivalents

244

475

Derivative financial instruments

19

21

Financial assets at fair value through income statement

6

13

Accounts receivable - trade

1,650

1,512

Inventories

1,541

1,423

Current tax assets

67

71

Prepayments

72

64

Other current assets

148

128

Current assets

3,747

3,707

Derivative financial instruments

118

144

Property, plant and equipment

2,254

2,293

Intangible assets

4,716

4,646

Deferred tax assets

125

112

Post-employment benefit plan assets

24

22

Financial assets at fair value through income statement

276

286

Interests in joint ventures and investments in associates

51

53

Other non-current assets

255

246

Non-current assets

7,819

7,802

Total assets

11,566

11,509

30 June

31 December

in millions of Swiss francs

2023

2022

Liabilities and equity

Short-term debt

1,407

356

Derivative financial instruments

20

70

Accounts payable - trade and others

845

861

Accrued payroll & payroll taxes

143

164

Current tax liabilities

127

123

Financial liability - own equity instruments

64

76

Provisions

33

9

Other current liabilities

251

266

Current liabilities

2,890

1,925

Derivative financial instruments

10

18

Long-term debt

4,073

4,649

Financial liability - own equity instruments

28

46

Provisions

66

75

Post-employment benefit plan liabilities

172

177

Deferred tax liabilities

273

270

Other non-current liabilities

108

112

Non-current liabilities

4,730

5,347

Total liabilities

7,620

7,272

Share capital

92

92

Retained earnings and reserves

6,446

6,614

Own equity instruments

(216)

(228)

Other components of equity

(2,381)

(2,246)

Equity attributable to equity holders of the parent

3,941

4,232

Non-controlling interests

5

5

Total equity

3,946

4,237

Total liabilities and equity

11,566

11,509

Givaudan - 2023 Financial summary  5

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Givaudan SA published this content on 20 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 July 2023 07:41:04 UTC.